Amyloid-β (Aβ) and tau pathology are the defining pathological features of AD.2 For many years, it has been possible to detect AD pathology (amyloid aggregation, tau tangles and neurodegeneration) using imaging and CSF biomarkers. The gene discussed is MAPT; the disease is Alzheimer disease.